PATENT CLAIM ANALYSIS

Application Number: 16014231
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["514", "259300"]

Abstract:
Compounds of Formula 0, Formula I, and Formula II and methods of use as Interleukin-1 Receptor Associated Kinase (IRAK4) inhibitors are described herein.

Claim (Index 6):
The compound of  claim 1 , or a stereoisomer or pharmaceutically acceptable salt thereof, wherein R 1  and R 4  are each hydrogen, and R 3  is Br, Cl, F, OCHF 2 , CHF 2 , or CF 3 .

Metadata:
- Claim Count in Document: 17.0
- Percentile: 94.0
- Lexical Diversity: 1.21739
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15905524', '15305390', '15247429', '15822493', '15305372']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8201183131320122
- 35 USC 102 Novelty (BERT): 0.5534050484139238
- Combined Prediction Score: 0.7934469866602034
- Mean Citation Score: 404.523194
- Max Citation Score: 418.23807
- Similarity Product: 363.14410909129685

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test